Skip to main content

Advertisement

Log in

What intensivists need to know on cardiac dysfunction in critically ill cancer patients

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Delmas C, Roubille F, Lamblin N et al (2022) Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. ESC Heart Fail 9:408–419. https://doi.org/10.1002/ehf2.13734

    Article  PubMed  Google Scholar 

  2. Gilon D, Iakobishvili Z, Leibowitz D (2022) The diagnosis and management of immune checkpoint inhibitor cardiovascular toxicity: myocarditis and beyond. Vaccines 10:304. https://doi.org/10.3390/vaccines10020304

    Article  PubMed  PubMed Central  Google Scholar 

  3. Burazor I, Aviel-Ronen S, Imazio M et al (2018) Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer 18:202. https://doi.org/10.1186/s12885-018-4070-x

    Article  PubMed  PubMed Central  Google Scholar 

  4. El Haddad D, Iliescu C, Yusuf SW et al (2015) Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion. J Am Coll Cardiol 66:1119–1128. https://doi.org/10.1016/j.jacc.2015.06.1332

    Article  PubMed  PubMed Central  Google Scholar 

  5. Costa IBS, Andrade FT, Carter D et al (2021) Challenges and management of acute coronary syndrome in cancer patients. Front Cardiovasc Med 8:590016. https://doi.org/10.3389/fcvm.2021.590016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bharadwaj A, Potts J, Mohamed MO et al (2020) Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 41:2183–2193. https://doi.org/10.1093/eurheartj/ehz851

    Article  CAS  PubMed  Google Scholar 

  7. Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603. https://doi.org/10.1093/eurheartj/ehz405

    Article  PubMed  Google Scholar 

  8. Mourad M, Chow-Chine L, Faucher M et al (2014) Early diastolic dysfunction is associated with intensive care unit mortality in cancer patients presenting with septic shock. Br J Anaesth 112:102–109. https://doi.org/10.1093/bja/aet296

    Article  CAS  PubMed  Google Scholar 

  9. Parker MM, Shelhamer JH, Bacharach SL et al (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483–490. https://doi.org/10.7326/0003-4819-100-4-483

    Article  CAS  PubMed  Google Scholar 

  10. Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938. https://doi.org/10.1056/NEJMoa1406761

    Article  CAS  PubMed  Google Scholar 

  11. Osawa T, Tajiri K, Ieda M, Ishizu T (2023) Clinical outcomes of takotsubo syndrome in patients with cancer: a systematic review and meta-analysis. Front Cardiovasc Med 10:1244808. https://doi.org/10.3389/fcvm.2023.1244808

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on takotsubo syndrome (part ii): diagnostic workup, outcome, and management. Eur Heart J 39:2047–2062. https://doi.org/10.1093/eurheartj/ehy077

    Article  PubMed  PubMed Central  Google Scholar 

  13. Varghese SS, Eekhoudt CR, Jassal DS (2021) Mechanisms of anthracycline-mediated cardiotoxicity and preventative strategies in women with breast cancer. Mol Cell Biochem 476:3099–3109. https://doi.org/10.1007/s11010-021-04152-y

    Article  CAS  PubMed  Google Scholar 

  14. Lyon AR, López-Fernández T, Couch LS et al (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43:4229–4361. https://doi.org/10.1093/eurheartj/ehac244

    Article  PubMed  Google Scholar 

  15. Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72:3158–3176. https://doi.org/10.1016/j.jacc.2018.09.072

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Djamel Mokart.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interests in relation to this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mokart, D., Vieillard-Baron, A. & Gilon, D. What intensivists need to know on cardiac dysfunction in critically ill cancer patients. Intensive Care Med 50, 766–772 (2024). https://doi.org/10.1007/s00134-024-07373-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-024-07373-z

Navigation